Clinical Trial Update: EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms

View source ↗

Summary

Clinical trial update describing a study investigating epigenomic determinants of the neuroendocrine phenotype as biomarkers for neuroendocrine neoplasms, curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed Neuroendocrine-non-neuroendocrine Neoplasm
• Neuroendocrine Neoplasm

Snippet

Sponsor: European Institute of Oncology | Conditions: Mixed Neuroendocrine-Non Neuroendocrine Neoplasm, Neuroendocrine Neoplasm | Status: RECRUITING